Friess Associates’s Exact Sciences EXAS Stock Holding History

Friess Associates’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,383	Closed	-$227K	–	96
2021 Q3	$227K	Buy	+2,383	New	+$252K	0.1%	81
2020 Q3	–	Sell	-177,662	Closed	-$15.4M	–	120
2020 Q2	$15.4M	Sell	177,662 -102,581	-37%	-$8.2M	1.44%	27
2020 Q1	$16.3M	Sell	280,243 -79,857	-22%	-$6.48M	1.62%	20
2019 Q4	$33.3M	Buy	+360,100	New	+$31.7M	2.32%	5
2019 Q3	–	Sell	-98,110	Closed	-$11.6M	–	115
2019 Q2	$11.6M	Hold	98,110	–	–	0.84%	53
2019 Q1	$8.5M	Hold	98,110	–	–	0.62%	61
2018 Q4	$6.19M	Buy	98,110 +6,110	+7%	+$419K	0.53%	65
2018 Q3	$7.26M	Sell	92,000 -196,550	-68%	-$12.8M	0.51%	63
2018 Q2	$17.3M	Buy	+288,550	New	+$15.5M	1.36%	36
2017 Q2	–	Sell	-180,235	Closed	-$4.26M	–	117
2017 Q1	$4.26M	Buy	+180,235	New	+$3.57M	0.4%	74
2016 Q3	–	Sell	-54,000	Closed	-$661K	–	148
2016 Q2	$661K	Buy	+54,000	New	+$407K	0.07%	88

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Friess Associates's EXAS Position: Q4 2021 in Review

Friess Associates sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 2,383 shares — an estimated $227K sold.

Friess Associates first reported a position in EXAS in Q2 2016 and held it in 11 quarters. The position peaked at $33.3M in Q4 2019. 595 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

Friess Associates reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
Friess Associates sold 2,383 Exact Sciences shares in Q4 2021, an estimated $227K.
Friess Associates first reported a position in Exact Sciences in Q2 2016 and held it in 11 quarters.
Friess Associates's Exact Sciences position peaked at $33.3M in Q4 2019.
595 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Friess Associates's 13F filing for Q4 2021, filed 11 Feb 2022.